Apolipoprotein E4 domain interaction accelerates diet-induced Atherosclerosis in hypomorphic arg-61 Apoe Mice

Delphine Eberlé, Roy Y. Kim, Fu Sang Luk, Nabora Soledad Reyes De Mochel, Nathalie Gaudreault, Victor R. Olivas, Nikit Kumar, Jessica M. Posada, Andrew C. Birkeland, Joseph H. Rapp, Robert L. Raffai

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Objectives-: Apolipoprotein (apo) E4 is an established risk factor for atherosclerosis, but the structural components underlying this association remain unclear. ApoE4 is characterized by 2 biophysical properties: domain interaction and molten globule state. Substituting Arg-61 for Thr-61 in mouse apoE introduces domain interaction without molten globule state, allowing us to delineate potential proatherogenic effects of domain interaction in vivo. Methods And Results-: We studied atherosclerosis susceptibility of hypomorphic Apoe mice expressing either Thr-61 or Arg-61 apoE (ApoeT or ApoeRmice). On a chow diet, both mouse models were normolipidemic with similar levels of plasma apoE and lipoproteins. However, on a high-cholesterol diet, ApoeR mice displayed increased levels of total plasma cholesterol and very-low-density lipoprotein as well as larger atherosclerotic plaques in the aortic root, arch, and descending aorta compared with ApoeT mice. In addition, evidence of cellular dysfunction was identified in peritoneal ApoeR macrophages which released lower amounts of apoE in culture medium and displayed increased expression of major histocompatibility complex class II molecules. Conclusions-: These data indicate that domain interaction mediates proatherogenic effects of apoE4 in part by modulating lipoprotein metabolism and macrophage biology. Pharmaceutical targeting of domain interaction could lead to new treatments for atherosclerosis in apoE4 individuals.

Original languageEnglish (US)
Pages (from-to)1116-1123
Number of pages8
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume32
Issue number5
DOIs
StatePublished - May 1 2012
Externally publishedYes

Fingerprint

Apolipoprotein E4
Atherosclerosis
Diet
Thoracic Aorta
Lipoproteins
VLDL Cholesterol
Peritoneal Macrophages
Apolipoproteins E
Atherosclerotic Plaques
Major Histocompatibility Complex
Culture Media
Macrophages
Cholesterol
Mouse apolipoprotein E (Arg61)
Pharmaceutical Preparations

Keywords

  • Apolipoprotein E4
  • Atherosclerosis
  • Domain interaction
  • Lipoproteins
  • Macrophages

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Eberlé, D., Kim, R. Y., Luk, F. S., De Mochel, N. S. R., Gaudreault, N., Olivas, V. R., ... Raffai, R. L. (2012). Apolipoprotein E4 domain interaction accelerates diet-induced Atherosclerosis in hypomorphic arg-61 Apoe Mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 32(5), 1116-1123. https://doi.org/10.1161/ATVBAHA.112.246389

Apolipoprotein E4 domain interaction accelerates diet-induced Atherosclerosis in hypomorphic arg-61 Apoe Mice. / Eberlé, Delphine; Kim, Roy Y.; Luk, Fu Sang; De Mochel, Nabora Soledad Reyes; Gaudreault, Nathalie; Olivas, Victor R.; Kumar, Nikit; Posada, Jessica M.; Birkeland, Andrew C.; Rapp, Joseph H.; Raffai, Robert L.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 32, No. 5, 01.05.2012, p. 1116-1123.

Research output: Contribution to journalArticle

Eberlé, D, Kim, RY, Luk, FS, De Mochel, NSR, Gaudreault, N, Olivas, VR, Kumar, N, Posada, JM, Birkeland, AC, Rapp, JH & Raffai, RL 2012, 'Apolipoprotein E4 domain interaction accelerates diet-induced Atherosclerosis in hypomorphic arg-61 Apoe Mice', Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 5, pp. 1116-1123. https://doi.org/10.1161/ATVBAHA.112.246389
Eberlé, Delphine ; Kim, Roy Y. ; Luk, Fu Sang ; De Mochel, Nabora Soledad Reyes ; Gaudreault, Nathalie ; Olivas, Victor R. ; Kumar, Nikit ; Posada, Jessica M. ; Birkeland, Andrew C. ; Rapp, Joseph H. ; Raffai, Robert L. / Apolipoprotein E4 domain interaction accelerates diet-induced Atherosclerosis in hypomorphic arg-61 Apoe Mice. In: Arteriosclerosis, Thrombosis, and Vascular Biology. 2012 ; Vol. 32, No. 5. pp. 1116-1123.
@article{a8423f6d90bc409fbadc03c1f9675622,
title = "Apolipoprotein E4 domain interaction accelerates diet-induced Atherosclerosis in hypomorphic arg-61 Apoe Mice",
abstract = "Objectives-: Apolipoprotein (apo) E4 is an established risk factor for atherosclerosis, but the structural components underlying this association remain unclear. ApoE4 is characterized by 2 biophysical properties: domain interaction and molten globule state. Substituting Arg-61 for Thr-61 in mouse apoE introduces domain interaction without molten globule state, allowing us to delineate potential proatherogenic effects of domain interaction in vivo. Methods And Results-: We studied atherosclerosis susceptibility of hypomorphic Apoe mice expressing either Thr-61 or Arg-61 apoE (ApoeT or ApoeRmice). On a chow diet, both mouse models were normolipidemic with similar levels of plasma apoE and lipoproteins. However, on a high-cholesterol diet, ApoeR mice displayed increased levels of total plasma cholesterol and very-low-density lipoprotein as well as larger atherosclerotic plaques in the aortic root, arch, and descending aorta compared with ApoeT mice. In addition, evidence of cellular dysfunction was identified in peritoneal ApoeR macrophages which released lower amounts of apoE in culture medium and displayed increased expression of major histocompatibility complex class II molecules. Conclusions-: These data indicate that domain interaction mediates proatherogenic effects of apoE4 in part by modulating lipoprotein metabolism and macrophage biology. Pharmaceutical targeting of domain interaction could lead to new treatments for atherosclerosis in apoE4 individuals.",
keywords = "Apolipoprotein E4, Atherosclerosis, Domain interaction, Lipoproteins, Macrophages",
author = "Delphine Eberl{\'e} and Kim, {Roy Y.} and Luk, {Fu Sang} and {De Mochel}, {Nabora Soledad Reyes} and Nathalie Gaudreault and Olivas, {Victor R.} and Nikit Kumar and Posada, {Jessica M.} and Birkeland, {Andrew C.} and Rapp, {Joseph H.} and Raffai, {Robert L.}",
year = "2012",
month = "5",
day = "1",
doi = "10.1161/ATVBAHA.112.246389",
language = "English (US)",
volume = "32",
pages = "1116--1123",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Apolipoprotein E4 domain interaction accelerates diet-induced Atherosclerosis in hypomorphic arg-61 Apoe Mice

AU - Eberlé, Delphine

AU - Kim, Roy Y.

AU - Luk, Fu Sang

AU - De Mochel, Nabora Soledad Reyes

AU - Gaudreault, Nathalie

AU - Olivas, Victor R.

AU - Kumar, Nikit

AU - Posada, Jessica M.

AU - Birkeland, Andrew C.

AU - Rapp, Joseph H.

AU - Raffai, Robert L.

PY - 2012/5/1

Y1 - 2012/5/1

N2 - Objectives-: Apolipoprotein (apo) E4 is an established risk factor for atherosclerosis, but the structural components underlying this association remain unclear. ApoE4 is characterized by 2 biophysical properties: domain interaction and molten globule state. Substituting Arg-61 for Thr-61 in mouse apoE introduces domain interaction without molten globule state, allowing us to delineate potential proatherogenic effects of domain interaction in vivo. Methods And Results-: We studied atherosclerosis susceptibility of hypomorphic Apoe mice expressing either Thr-61 or Arg-61 apoE (ApoeT or ApoeRmice). On a chow diet, both mouse models were normolipidemic with similar levels of plasma apoE and lipoproteins. However, on a high-cholesterol diet, ApoeR mice displayed increased levels of total plasma cholesterol and very-low-density lipoprotein as well as larger atherosclerotic plaques in the aortic root, arch, and descending aorta compared with ApoeT mice. In addition, evidence of cellular dysfunction was identified in peritoneal ApoeR macrophages which released lower amounts of apoE in culture medium and displayed increased expression of major histocompatibility complex class II molecules. Conclusions-: These data indicate that domain interaction mediates proatherogenic effects of apoE4 in part by modulating lipoprotein metabolism and macrophage biology. Pharmaceutical targeting of domain interaction could lead to new treatments for atherosclerosis in apoE4 individuals.

AB - Objectives-: Apolipoprotein (apo) E4 is an established risk factor for atherosclerosis, but the structural components underlying this association remain unclear. ApoE4 is characterized by 2 biophysical properties: domain interaction and molten globule state. Substituting Arg-61 for Thr-61 in mouse apoE introduces domain interaction without molten globule state, allowing us to delineate potential proatherogenic effects of domain interaction in vivo. Methods And Results-: We studied atherosclerosis susceptibility of hypomorphic Apoe mice expressing either Thr-61 or Arg-61 apoE (ApoeT or ApoeRmice). On a chow diet, both mouse models were normolipidemic with similar levels of plasma apoE and lipoproteins. However, on a high-cholesterol diet, ApoeR mice displayed increased levels of total plasma cholesterol and very-low-density lipoprotein as well as larger atherosclerotic plaques in the aortic root, arch, and descending aorta compared with ApoeT mice. In addition, evidence of cellular dysfunction was identified in peritoneal ApoeR macrophages which released lower amounts of apoE in culture medium and displayed increased expression of major histocompatibility complex class II molecules. Conclusions-: These data indicate that domain interaction mediates proatherogenic effects of apoE4 in part by modulating lipoprotein metabolism and macrophage biology. Pharmaceutical targeting of domain interaction could lead to new treatments for atherosclerosis in apoE4 individuals.

KW - Apolipoprotein E4

KW - Atherosclerosis

KW - Domain interaction

KW - Lipoproteins

KW - Macrophages

UR - http://www.scopus.com/inward/record.url?scp=84860221644&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860221644&partnerID=8YFLogxK

U2 - 10.1161/ATVBAHA.112.246389

DO - 10.1161/ATVBAHA.112.246389

M3 - Article

C2 - 22441102

AN - SCOPUS:84860221644

VL - 32

SP - 1116

EP - 1123

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 5

ER -